Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0P2BD
|
|||
Former ID |
DIB014008
|
|||
Drug Name |
SAFIRONIL
|
|||
Synonyms |
Hoe-277; Safironil; N,N'-Bis(3-methoxypropyl)pyridine-2,4-dicarboxamide
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Transplant rejection [ICD-11: NE84; ICD-9: 279.5, 996] | Phase 1 | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H23N3O4
|
|||
Canonical SMILES |
COCCCNC(=O)C1=CC(=NC=C1)C(=O)NCCCOC
|
|||
InChI |
1S/C15H23N3O4/c1-21-9-3-6-17-14(19)12-5-8-16-13(11-12)15(20)18-7-4-10-22-2/h5,8,11H,3-4,6-7,9-10H2,1-2H3,(H,17,19)(H,18,20)
|
|||
InChIKey |
HLSXICGBWKECLM-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 134377-69-8
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Prolyl 4-hydroxylasesubunit alpha-1 (P4HA1) | Target Info | Modulator | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Antifibrogenic therapies in chronic HCV infection. Curr Drug Targets Infect Disord. 2001 Aug;1(2):227-40. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.